(lp0
S'Dynavax Technologies Corporation  Files An 8-K Results of ... Market Exclusive - Mar 13, 2017 On March 13, 2017, Dynavax Technologies Corporation  issued a press release announcing its financial results for the quarter and year ended December 31, 2016.Dynavax Technologies reports 4Q loss - Yahoo Financeanalysts Recommendations: Dynavax Technologies Corporation  - News Oracle'
p1
aS'Stock Update : Dynavax Technologies Corporation Reports 4Q and ... Smarter Analyst - Mar 13, 2017 Dynavax Technologies Corporation  reported financial results for the fourth quarter and year ended December 31, 2016.'
p2
aS"Dynavax Technologies Corporation  Presents Clinical Data from SD-101 at ... Smarter Analyst - Mar 6, 2017 Dynavax Technologies Corporation  announced the presentation of findings in patients with metastatic melanoma in the dose escalation phase of an ongoing Phase 1b/2 study investigating SD-101, Dynavax's intratumoral TLR9 agonist,&nbsp;...UPDATE: Dynavax shares reverse premarket losses to open flat - MarketWatch"
p3
aS"Dynavax Technologies Corporation  Looks Like A PDUFA Winner Insider Financial - Mar 2, 2017 One such opportunity lies in Dynavax Technologies Corporation . This is a stock that traders love to hate. For the past twelve months and more, it's been repeatedly beaten down based on a drawn out approval pathway for its lead hepatitis B&nbsp;...Did Market Over-React to FDA News on Dynavax Technologies Corporation (NASDAQ ... - StockNewsUnion"
p4
aS"Dynavax Technologies Corporation  Shares Jump on NDA Acceptance Smarter Analyst - Feb 28, 2017 Dynavax Technologies Corporation  investors cheer the news that the FDA has accepted for review Dynavax's responses to the Complete Response Letter  issued by the FDA in November 2016 for the Biologics License Application for&nbsp;...Price Mover of Last Trading Day: Dynavax Technologies Corporation  - Is storiesDynavax Announces FDA Acceptance for Review of Its Complete Response to ... - Marketwired "
p5
aS'Dynavax: A Wee Glimmer Of Hope Seeking Alpha - Mar 3, 2017 Dynavax stalwarts had been throwing in so many towels that there were few left to throw. So great was the despair that the teeniest bit of good news rocketed the stock upwards.'
p6
aS'Dynavax In 2017: Hero Or Zero? Seeking Alpha - Jan 18, 2017 The deeper I have gone into the Dynavax story, the more I have come to believe that its own recurring failures are the author of its current unhappy situation.'
p7
aS"Stock Update : Here's Why Dynavax Technologies Corporation Shares ... Smarter Analyst - Nov 14, 2016 After a long debate, Dynavax Technologies Corporation's  hepatitis B vaccine Heplisav ended up sinking the company's shares by nearly 70% in pre-market trading.Dynavax: What's Next For The Company? - Seeking AlphaWhy Dynavax Technologies Shares Are Crashing 63% Today - Motley Fool"
p8
aS'Dynavax Technologies: Valuation Of The Immune-Oncology Pipeline Seeking Alpha - Jan 17, 2017 Dynavax management seems to be positioning it as an immune-oncology company for near future. We think investors are under-appreciating the future commercial potential of this immune-oncology pipeline .'
p9
aS'William Blair Slices the Price Target on Dynavax Technologies Corporation ... Smarter Analyst - Nov 16, 2016 That was a rough week for investors in Dynavax Technologies Corporation , after the biotech firm announced on Monday, November 14th that it had received a Complete Response Letter  from the FDA for the Heplisav Biologics&nbsp;...'
p10
a.